Cite
HARVARD Citation
Kapp, K. et al. (2019). EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy. Journal for immunotherapy of cancer. 7 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kapp, K. et al. (2019). EnanDIM - a novel family of L-nucleotide-protected TLR9 agonists for cancer immunotherapy. Journal for immunotherapy of cancer. 7 (1), p. . [Online].